4//SEC Filing
Wang Xiaolin 4
Accession 0001567619-21-022404
CIK 0001628171other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:33 PM ET
Size
4.9 KB
Accession
0001567619-21-022404
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2021-12-17$24.41/sh−257$6,273→ 11,938 total
Footnotes (2)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Includes 9,100 RSUs.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001849181
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:33 PM ET
- Size
- 4.9 KB